2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the …

JU Doherty, TJ Gluckman, WJ Hucker… - Journal of the American …, 2017 - jacc.org
Periprocedural management of anticoagulation is a common clinical conundrum that
involves a multidisciplinary team, cuts across many specialties, and varies greatly between …

Distal versus conventional radial access for coronary angiography and intervention: the DISCO RADIAL trial

A Aminian, GA Sgueglia, M Wiemer, J Kefer… - Cardiovascular …, 2022 - jacc.org
Background Currently, transradial access (TRA) is the recommended access for coronary
procedures because of increased safety, with radial artery occlusion (RAO) being its most …

Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials

G Ferrante, SV Rao, P Jüni, BR Da Costa… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The aim of this study was to provide a quantitative appraisal of the effects on
clinical outcomes of radial access for coronary interventions in patients with coronary artery …

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

T Cuisset, P Deharo, J Quilici, TW Johnson… - European heart …, 2017 - academic.oup.com
Abstract Aims Newer P2Y12 blockers (prasugrel and ticagrelor) demonstrated significant
ischaemic benefit over clopidogrel after acute coronary syndrome (ACS). However, both …

Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation

L Fauchier, A Cinaud, F Brigadeau, A Lepillier… - Journal of the American …, 2018 - jacc.org
Background: Transcatheter left atrial appendage (LAA) occlusion is an alternative strategy
for stroke prevention in patients with atrial fibrillation (AF). Objectives: This study sought to …

Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial

R Galea, F De Marco, N Meneveau, A Aminian… - Circulation, 2022 - Am Heart Assoc
Background: No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of …

LV Boersma, H Ince, S Kische… - Circulation …, 2019 - Am Heart Assoc
Background: Left atrial appendage occlusion with WATCHMAN has emerged as viable
alternative to vitamin K antagonists in randomized controlled trials. Evaluating real-life …

[HTML][HTML] Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve

HP Guimaraes, RD Lopes… - … England Journal of …, 2020 - Mass Medical Soc
Background The effects of rivaroxaban in patients with atrial fibrillation and a bioprosthetic
mitral valve remain uncertain. Methods In this randomized trial, we compared rivaroxaban …

[HTML][HTML] One-year outcomes after PCI strategies in cardiogenic shock

H Thiele, I Akin, M Sandri… - … England Journal of …, 2018 - Mass Medical Soc
Background Among patients with acute myocardial infarction, cardiogenic shock, and
multivessel coronary artery disease, the risk of a composite of death from any cause or …

Optical coherence tomography–guided or intravascular ultrasound–guided percutaneous coronary intervention: the OCTIVUS randomized clinical trial

DY Kang, JM Ahn, SC Yun, SH Hur, YK Cho, CH Lee… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Intravascular imaging–guided percutaneous coronary intervention (PCI)
with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) showed …